Enterprise Value
5.649M
Cash
949K
Avg Qtr Burn
-2.236M
Short % of Float
2.43%
Insider Ownership
29.56%
Institutional Own.
7.13%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
BCDA-02 CardiAMP cell therapy Details Heart failure, Myocardial ischemia | Phase 3 Data readout | |
BCDA-01 CardiAMP cell therapy Details Ischemic stroke, Heart failure | Phase 3 Data readout | |
BCDA-03 CardiALLO cell therapy Details Ischemic stroke, Heart failure | Phase 1/2 Data readout |